Colin Dollery
Colin Dollery is a renowned British physician and pharmacologist, best known for his significant contributions to the field of Clinical Pharmacology. He has held numerous prestigious positions throughout his career, including the Senior Consultant Physician at the Royal Postgraduate Medical School, Hammersmith Hospital, and the Dean of the Faculty of Medicine at the Imperial College of Science, Technology and Medicine.
Early Life and Education[edit | edit source]
Colin Dollery was born in the United Kingdom. He completed his medical education at the University of Oxford, where he developed a keen interest in pharmacology. He further pursued his interest in this field and went on to specialize in Clinical Pharmacology.
Career[edit | edit source]
Dollery's career in medicine and pharmacology spans several decades. He served as the Senior Consultant Physician at the Royal Postgraduate Medical School, Hammersmith Hospital, where he was instrumental in advancing the field of Clinical Pharmacology. He also held the position of Dean of the Faculty of Medicine at the Imperial College of Science, Technology and Medicine, where he played a pivotal role in shaping the future of medical education and research.
His research primarily focused on cardiovascular pharmacology, particularly the pharmacology of Antihypertensive Drugs. He has published numerous research papers and articles in esteemed medical and pharmacological journals, contributing significantly to the understanding and treatment of cardiovascular diseases.
Contributions to Pharmacology[edit | edit source]
Dollery's contributions to the field of pharmacology are extensive. He is particularly known for his work on the pharmacology of antihypertensive drugs. His research has helped in the development of new drugs and treatment strategies for hypertension, a major risk factor for cardiovascular diseases.
He has also made significant contributions to the field of clinical pharmacology. His work has helped to establish clinical pharmacology as a vital medical specialty, and he has been a strong advocate for the integration of pharmacology into the broader medical curriculum.
Honours and Awards[edit | edit source]
In recognition of his contributions to medicine and pharmacology, Dollery has received numerous honours and awards. These include the Wellcome Gold Medal in Pharmacology and the Cameron Prize for Therapeutics of the University of Edinburgh.
See Also[edit | edit source]
- Clinical Pharmacology
- Antihypertensive Drugs
- Imperial College of Science, Technology and Medicine
- Royal Postgraduate Medical School
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
